View by Year:
Ilkanizadeh S, Lau J, Huang M, Foster DJ, Wong R, Frantz A, Wang S, Weiss WA, Persson AI
Glial progenitors as targets for transformation in glioma.
Advances in cancer research, 2014;121:1-65.
Rivera LB, Bergers G
Location, location, location: macrophage positioning within tumors determines pro- or antitumor activity.
Cancer cell, Dec-9-2013;24(6):687-9.
Fan QW, Cheng CK, Gustafson WC, Charron E, Zipper P, Wong RA, Chen J, Lau J, Knobbe-Thomsen C, Weller M, Jura N, Reifenberger G, Shokat KM, Weiss WA
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.
Cancer cell, Oct-14-2013;24(4):438-49.
Huang M, Weiss WA
Neuroblastoma and MYCN.
Cold Spring Harbor perspectives in medicine, Oct-2013;[epublish]3(10):a014415.
Bainer R, Weaver V
Cell biology. Strength under tension.
Science (New York, N.Y.), Aug-30-2013;341(6149):965-6.
Swartling FJ, Hede SM, Weiss WA
What underlies the diversity of brain tumors?
Cancer metastasis reviews, Jun-2013;32(1-2):5-24.
Jahangiri A, De Lay M, Miller LM, Carbonell WS, Hu YL, Lu K, Tom MW, Paquette J, Tokuyasu TA, Tsao S, Marshall R, Perry A, Bjorgan KM, Chaumeil MM, Ronen SM, Bergers G, Aghi MK
Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.
Clinical cancer research : an official journal of the American Association for Cancer Research, Apr-1-2013;19(7):1773-83.  Epub 2013 Mar 21.
Swartling FJ, Bolin S, Phillips JJ, Persson AI
Signals that regulate the oncogenic fate of neural stem cells and progenitors.
Experimental neurology, Jan-31-2013;[Epub ahead of print].
Lu KV, Bergers G
Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma.
CNS oncology, Jan-2013;2(1):49-65.
Paszek MJ, DuFort CC, Rubashkin MG, Davidson MW, Thorn KS, Liphardt JT, Weaver VM
Scanning angle interference microscopy reveals cell dynamics at the nanoscale.
Nature methods, Aug-2012;[epublish]9(8):825-7.
Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, Park M, Bergers G
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex.
Cancer cell, Jul-10-2012;22(1):21-35.
Chesler L, Weiss WA
Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma.
Seminars in cancer biology, Oct-2011;21(4):245-55.  Epub 2011 Sep 21.
[    1  2   View All ]